21 CFR 868.5480
§ 868.5480 Isocapnic ventilation device.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 868.5480, § 868.5480 Isocapnic ventilation device, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/89808
- Permanent ID
ys:prov:89808@1- SHA-256
f1d058a94b0623f534016b7789280441eba6a3f6559ed361fa9838a21a6da0c8
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Identification. An isocapnic ventilation device is a prescription device used to administer a blend of carbon dioxide and oxygen gases to a patient to induce hyperventilation. This device may be labeled for use with breathing circuits made of reservoir bags (§ 868.5320), oxygen cannulas (§ 868.5340), masks (§ 868.5550), valves (§ 868.5870), resuscitation bags (§ 868.5915), and/or tubing (§ 868.5925).
(b) Classification. Class II (special controls). The special controls for this device are:
(1) Nonclinical performance testing data must demonstrate that the device performs as intended under anticipated conditions of use, including the following performance characteristics:
(i) Gas concentration accuracy testing for the range of intended concentrations;
(ii) Airway pressure delivery accuracy testing;
(iii) Supplemental O2 flowrate accuracy testing;
(iv) Alarm testing; and
(v) Use life testing.
(2) The patient-contacting components of the device must be demonstrated to be biocompatible.
(3) Labeling must include the following:
(i) Instructions for use;
(ii) A precaution that monitoring of capnography is necessary during treatment with non-spontaneously breathing patients; and
(iii) Use life specification.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.